| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 05/28/2008 | CN100390280C Gene of expressing regeneration enhancement factor of recombined human liver in full lenght, and method for preparing regeneration enhancement factor of recombined human liver in full length, and use |
| 05/28/2008 | CN100390279C Altered polypeptides with increased half-life |
| 05/28/2008 | CN100390202C Fusion protein of tumour new-born blood vessel-specific bonding polypeptide and recombinant human Tum-5, and its preparation method |
| 05/28/2008 | CN100390201C Fusion protein with reinforced erythrocytin activity in vivo |
| 05/28/2008 | CN100390193C Methods and reagents for detecting endotoxin |
| 05/28/2008 | CA2601368A1 Monoclonal and polyclonal antibodies to equine albumin and hemoglobin and apparatus and methods using the antibodies in the identification and localization of ulcers and other digestive tract bleeding in equines |
| 05/27/2008 | US7378512 Comprises expression vector coding pestivirus protease for transformation and propagation in escherichia; bioreactor and heterologous gene expression |
| 05/27/2008 | US7378507 for pharmaceuticals, diagnostics, biosensors and bioreactors; thrombolytic agents, interferons, interleukins, erythropoietins, colony stimulating factors, and cytokines; solid phase synthesis |
| 05/27/2008 | US7378504 Human monoclonal antibodies to Fc gamma receptor I (CD64) |
| 05/27/2008 | US7378502 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis |
| 05/27/2008 | US7378487 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders |
| 05/27/2008 | US7378393 Recombinant anticoagulant proteins |
| 05/27/2008 | US7378273 Plasmid construct comprising hybrid alpha -lactalbumin promoter for use as gene transfer and expression tool in genetic engineering; gene therapy and tissue engineering |
| 05/27/2008 | US7378272 Mosquito cell culture for propagation of sindbis viral vectors; genetic engineering and vehicles for gene transfer |
| 05/27/2008 | US7378263 In vivo site-specific incorporation of N-acetyl-galactosamine amino acids in eubacteria |
| 05/27/2008 | US7378261 using an enzyme of given amino acid sequence having para-hydroxycinnamic acid decarboxylase activity; solvent extraction, high yield; also biosynthesis of derivatives such as para-acetoxystyrene |
| 05/27/2008 | US7378256 Aspergillus niger promoter for expressing genes in host cells |
| 05/27/2008 | US7378252 Signal transduction |
| 05/27/2008 | US7378248 Fusion proteins; libraries; monitoring ubiquitination |
| 05/27/2008 | US7378101 Immunogenic mixture comprising porphyromonas inactivated whole cell preparation for use in generating immunotherapeutic protein for prevention and treatment of oral disease in companion animals |
| 05/27/2008 | US7378093 Broadly cross-reactive neutralizing antibodies against Human Immunodeficiency Virus selected by Env-CD4-co-receptor complexes |
| 05/27/2008 | US7378091 Antibodies against carbonic anhydrase IX (CA IX) tumor antigen |
| 05/27/2008 | US7378078 Chimeric polypeptide comprising bioluminescent/chemiluminescent, kinase and/or silencing domains for monitoring efficacy of therapeutic agents |
| 05/27/2008 | CA2258494C Polypeptides capable of forming antigen binding structures with specificity for the rhesus d antigens, the dna encoding them and the process for their preparation and use |
| 05/27/2008 | CA2213813C Methods and compositions for secretion of heterologous polypeptides |
| 05/27/2008 | CA2120358C Hormone analogs with multiple ctp extensions |
| 05/22/2008 | WO2008060941A2 Expression system of nell peptide |
| 05/22/2008 | WO2008059837A1 Antibody against aflatoxins, support using the antibody, method of immunologically detecting aflatoxins and method of concentrating and purifying aflatoxins |
| 05/22/2008 | WO2008059823A1 Translation and synthesis of polypeptide having nonnative structure at n-terminus and application thereof |
| 05/22/2008 | WO2008059616A1 Antibody recognizing c-domain of midkine |
| 05/22/2008 | WO2008058380A1 Cancerous disease modifying antibodies |
| 05/22/2008 | WO2008058379A1 Cancerous disease modifying antibodies |
| 05/22/2008 | WO2008036392A9 Genetically programmed expression of selectively sulfated proteins in eubacteria |
| 05/22/2008 | WO2008008950A3 Methods for producing secreted polypeptides having biological activity |
| 05/22/2008 | US20080120732 Method for Improved Transgene Expression |
| 05/22/2008 | US20080119638 Human endothelin receptor |
| 05/22/2008 | US20080119636 Methods and materials for cancer treatment |
| 05/22/2008 | US20080119430 Compositions and Methods for Angiogenesis-Related Molecules and Treatments |
| 05/22/2008 | US20080119409 Method for the production of conjugates of insulin-like growth factor-1 and poly(ethylene glycol) |
| 05/22/2008 | US20080119403 Haparin-Binding Protein Modified with Heparan Sulfate Sugar Chains, Process for Producing the Same and Pharmaceutical Compositions Containing the Same |
| 05/22/2008 | US20080119400 Regulators of complement activation (RCA); diagnosis/therapy of complement system for autoimmune disease treatment; open reading frames; point mutations; membrane cofactor/decay accelerating factor/factor H |
| 05/22/2008 | US20080119399 An EGFR-reactive cytotoxic T lymphocyte which recognizes a complex between the EGFR-derived peptide and human leukocyte antigen (HLA) molecule; anticarcinogenic agent |
| 05/22/2008 | US20080119398 Modified Thioredoxin |
| 05/22/2008 | US20080119395 Novel Depsipeptides and Process for Preparing Same |
| 05/22/2008 | US20080119390 Synthetic human peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus |
| 05/22/2008 | US20080118952 Polynucelotides encoding novel variants of the TRP channel family member, LTRPC3 |
| 05/22/2008 | US20080118951 Nogo receptor homologues and their use |
| 05/22/2008 | US20080118950 Method For Production Of A Heterologous Protein Using Yeast-Type Host Cells |
| 05/22/2008 | US20080118949 Intracellular Production Of A Nuclease |
| 05/22/2008 | US20080118948 Generating vector comprising regulatory sequences associated with protein translation elongation factor TU (P EF-TU); improving exogenous gene expression |
| 05/22/2008 | US20080118947 Isolating connective tissue protein from porcine bone tissue via pepsin digestion, salt fractionation and ethanol extraction |
| 05/22/2008 | US20080118937 Monoclonal antibody for detecting staphylococcal infection |
| 05/22/2008 | US20080118936 Polyclonal antibodies against fibrinogen degradation products and associated methods of production and use |
| 05/22/2008 | US20080118933 Methods of screening for inhibitors of antiplasmin cleaving enzyme |
| 05/22/2008 | US20080118909 Methods and kits for isolating sperm cells |
| 05/22/2008 | US20080118528 Expressing a construct comprising the prM and E genes in a baculoviral expression cassette and cloned under the control of a promoter in insect cells; culturing; separation by lysis; diagnostic and therapeutic vaccines; vaccination |
| 05/22/2008 | US20080118525 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
| 05/22/2008 | US20080118523 Chimeric polypeptide comprising tissue inhibitor of matrix metalloproteinases-3 (TIMP-3) for use in treatment and prevention of arthritic and degenerative joint disorders |
| 05/22/2008 | US20080118522 Using lymphocyte receptor specific immunoglobulins to treat and prevent viral infection, asthma, cardiovascular, autoimmune, cell proliferative and inflammatory disorders |
| 05/22/2008 | US20080118512 Antibodies binding to the extracellular domain of the receptor tyrosine kinase ALK |
| 05/22/2008 | US20080118511 PD-L2 Molecules: Novel PD-1 Ligands and Uses Therefor |
| 05/22/2008 | US20080118510 Vegf-related protein |
| 05/22/2008 | US20080118508 Complement pathway inhibitors binding to C5 and C5a without preventing formation of C5b |
| 05/22/2008 | US20080118505 Reagents and treatment methods for autoimmune diseases |
| 05/22/2008 | US20080118502 Using metalloproteinase modulators as stimulatory tools in tissue regeneration; tissue engineering |
| 05/22/2008 | US20080118501 Antibodies with enhanced antibody-dependent cellular cytotoxicity activity, methods of their production and use |
| 05/22/2008 | US20080118495 Using avian cells as screening tools in monitoring and/or identifying viricidal agents |
| 05/22/2008 | CA2668496A1 Cancerous disease modifying antibodies |
| 05/22/2008 | CA2668484A1 Cancerous disease modifying antibodies 180706-02 |
| 05/21/2008 | EP1923465A1 Inhibitor protein for the WNT signal pathway |
| 05/21/2008 | EP1923402A1 Method for determination of enzymatic activity |
| 05/21/2008 | EP1922412A2 Humanized antibody conjugates and related methods, assays, reagents, and kits |
| 05/21/2008 | EP1922334A1 Tumor-associated peptides binding to human leukocyte antigen (hla) class i or ii molecules and related anti-cancer vaccine |
| 05/21/2008 | EP1668161A4 Fragment complementation assays for g-protein-coupled receptors and their signaling pathways |
| 05/21/2008 | EP1655375B1 Process for producing extract for cell-free protein synthesis and cell extract produced thereby |
| 05/21/2008 | EP1467753B1 Recombinant herpesvirus of turkeys and use thereof |
| 05/21/2008 | EP1366158B1 Trp8 markers for cancer |
| 05/21/2008 | EP1287130B1 Mammalian cytokine receptor subunit proteins, related reagents and methods |
| 05/21/2008 | EP1003545B1 Heparin-binding growth factor (hbgf) polypeptides |
| 05/21/2008 | CN101182564A Function aquatic peptide capable of promoting growth of aquatic animals and enhancing disease resistance and method of producing the same |
| 05/21/2008 | CN101182357A Globefish skin active collagen and method for preparing peptide thereof |
| 05/21/2008 | CN100389196C Cancer cell vaccine |
| 05/21/2008 | CN100389127C I (mycobacterium tuberculosis) superoxide dismutase |
| 05/21/2008 | CN100389124C Non-inducing expressing gene engineering strain and structural process and application thereof |
| 05/20/2008 | US7375205 Elongase genes and uses thereof |
| 05/20/2008 | US7375199 Cancer-associated genes |
| 05/20/2008 | US7375196 PRO19814 antibodies |
| 05/20/2008 | US7375195 Vectors with DNA encoding pro polypeptides |
| 05/20/2008 | US7375194 For therapy of Huntington's disease |
| 05/20/2008 | US7375182 Growth factor homolog zvegf4 |
| 05/20/2008 | US7375179 PRO19680 polypeptides |
| 05/20/2008 | US7375093 Nuclear receptor-based inducible gene expression system |
| 05/20/2008 | US7375081 Synergist mixture with lipopeptide and cyclic hexapeptide |
| 05/20/2008 | US7375079 Recombinant expression system for production of a peptide capable of inhibiting the protease activity of Botulinum toxin B or tetanus toxin which expression system comprises a nucleotide sequence encoding the peptide operably linked to a control sequence for effecting expression |
| 05/20/2008 | US7374922 Starch debranching enzymes |
| 05/20/2008 | US7374921 Cellulase tolerant to surfactants |
| 05/20/2008 | US7374918 Enhanced sarcosine oxidase for use in measurement of creatinine concentration in human serum or urine; diagnosing renal disorders |
| 05/20/2008 | US7374917 Enzymatic polypeptide comprising aldo-keto reductases activity for use in conversion of glucose to vitamin C; bioreactors |
| 05/20/2008 | US7374912 Nucleic acids encoding chimeric interleukin-6 soluble receptor/ligand protein, analogs thereof and uses thereof |
| 05/20/2008 | US7374911 Cytokine polypeptide for use in diagnosis, prevention and treatment of immunological and/or inflammatory disorders |